Livzon Pharma Announces RMB 12.39 Cash Dividend per 10 Shares for Q3 2026, Payment Slated for 23 December 2026

Bulletin Express10-23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has declared an ordinary third-quarter cash dividend of RMB 12.39 per 10 shares for the reporting period ended 30 September 2026.

Shareholder approval is scheduled for 12 November 2026. The shares will trade ex-dividend on 25 November 2026, with the record date set for 26 November 2026. Share transfers must be lodged with Tricor Investor Services Limited by 16:30 on 26 November 2026.

Dividend cheques will be dispatched on or before 23 December 2026. Industrial and Commercial Bank of China (Asia) Limited will act as the Hong Kong paying agent. The payment currency for H-shareholders and the applicable exchange rate will be announced closer to the distribution date.

Withholding tax will be applied at 10% for non-resident enterprise shareholders and 20% for resident individual shareholders registered within the PRC.

The company’s board consists of Executive Directors Liu Daping (Chairman and President) and Tang Yanggang (Vice Chairman); Non-Executive Directors Lin Nanqi and Qiu Qingfeng; Employee Representative Director Ran Yongmei; and Independent Non-Executive Directors Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment